EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseVergleichsstudie

Effectiveness and safety of acetazolamide plus loop diuretics in acute congestive heart failure: A living systematic review - Version 2026 1.0

Franco Schettino-Orellana iD, Felipe Vega González iD, Iván Godoy Cofré iD, Florencia Honorato Labarca iD, Rodrigo Sepúlveda Palamara iD, Macarena Morel-Marambio iD, Luis Ortiz-Muñoz iD

Medwave · 30.07.2026 · 26 (06) · e3217-e3217

DOI: 10.5867/medwave.2026.06.3217 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Medwave, online erschienen am 30.07.2026. Verfasst von Franco Schettino-Orellana und 6 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Department, Pontificia Universidad Católica de Chile, Santiago, Chile. Hauptthemen laut MEDLINE: Acetazolamide, Heart Failure, Sodium Potassium Chloride Symporter Inhibitors.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This living systematic review Version 1.0 aims to provide a timely, rigorous and continuously updated summary of the evidence on the use of acetazolamide plus loop diuretics in acute congestive heart failure compared to loop diuretics.

Methods

We conducted a comprehensive search in CENTRAL, EMBASE, MEDLINE, and between database inception and September 2025. No language, publication date or status restrictions were applied. Two reviewers independently screened eligible studies, according to predefined selection criteria, and extracted data using a predesigned form. We performed meta-analyses using random-effects models and assessed overall certainty in evidence using the GRADE approach. The quality of the evidence was assessed using the Cochrane risk-of-bias tool. This review was registered in PROSPERO (CRD42024575267).

Results

Of 732 records identified, five randomized trials were included, with a total of 1050 participants. The evidence is very uncertain about the effect of adding acetazolamide to loop diuretics in decongestion observed at 72 hours (risk ratio: 1.17, 95% confidence interval: 0.96 to 1.44). Low certainty evidence shows adding acetazolamide to loop diuretics may increase natriuresis at 24 hours (mean difference 38.43, 95% confidence interval: 19.42 to 57.43). No significant differences were found between groups in accumulative diuresis at 48 hours, all-cause mortality, readmission due to heart failure or worsening renal function.

Conclusions

Evidence suggests that it is necessary to promote further investigations regarding the use of acetazolamide plus loop diuretics in acute congestive heart failure. More robust, standardized, long-term studies are needed, and conclusions may change as new data emerge.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetazolamideHeart FailureSodium Potassium Chloride Symporter InhibitorsHumansAcute DiseaseRandomized Controlled Trials as TopicDrug Therapy, CombinationTreatment Outcome

Stichwörter der Autor:innen

Systematic reviewacetazolamidediureticheart failure

Substanzen

AcetazolamideSodium Potassium Chloride Symporter Inhibitors

Autor:innen und Institutionen

  • Internal Medicine Department, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Nephrology Department, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • UC Evidence Center, Cochrane Chile Associated Center, Pontificia Universidad Católica de Chile, Santiago, Chile.

ORCID-Profile: Franco Schettino-Orellana, Felipe Vega González, Iván Godoy Cofré, Florencia Honorato Labarca, Rodrigo Sepúlveda Palamara, Macarena Morel-Marambio, Luis Ortiz-Muñoz

Zitieren

APA

Schettino-Orellana, F., Vega González, F., Godoy Cofré, I., Honorato Labarca, F., Sepúlveda Palamara, R., Morel-Marambio, M., & Ortiz-Muñoz, L. (2026). Effectiveness and safety of acetazolamide plus loop diuretics in acute congestive heart failure: A living systematic review - Version 2026 1.0. Medwave, 26(06), e3217-e3217. https://doi.org/10.5867/medwave.2026.06.3217

Vancouver

Schettino-Orellana F, Vega González F, Godoy Cofré I, Honorato Labarca F, Sepúlveda Palamara R, Morel-Marambio M, et al. Effectiveness and safety of acetazolamide plus loop diuretics in acute congestive heart failure: A living systematic review - Version 2026 1.0. Medwave. 2026;26(06):e3217-e3217. doi:10.5867/medwave.2026.06.3217

BibTeX
@article{SchettinoOrellana2026,
  author = {Schettino-Orellana, Franco and Vega González, Felipe and Godoy Cofré, Iván and Honorato Labarca, Florencia and Sepúlveda Palamara, Rodrigo and Morel-Marambio, Macarena and Ortiz-Muñoz, Luis},
  title = {Effectiveness and safety of acetazolamide plus loop diuretics in acute congestive heart failure: A living systematic review - Version 2026 1.0},
  journal = {Medwave},
  year = {2026},
  volume = {26},
  number = {06},
  pages = {e3217--e3217},
  doi = {10.5867/medwave.2026.06.3217}
}
Kostenlos starten →